Evidence map›Paper›PMID 37205198›Full record

ArticleFrontiers in oncology2023

Molecular characteristics of multiple primary pulmonary nodules under a three-dimensional reconstruction model and relevant multi-omics analyses: a case report.

Zhilin Luo, Yajie Xiao, Chengwen Luo, Liping Zhang, Runquan Zhou, Zhikun Zhao, Chao Sun, Dongfang Wu, Tianhu Wang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhilin LuoDepartment of Thoracic Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yajie XiaoDepartment of Medicine, YuceBio Technology Co. Ltd., Shenzhen, China.
Chengwen LuoDepartment of Thoracic Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Liping ZhangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Runquan ZhouDepartment of Thoracic Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhikun ZhaoDepartment of Medicine, YuceBio Technology Co. Ltd., Shenzhen, China.
Chao SunDepartment of Medicine, YuceBio Technology Co. Ltd., Shenzhen, China.
Dongfang WuDepartment of Medicine, YuceBio Technology Co. Ltd., Shenzhen, China.
Tianhu WangDepartment of Thoracic Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Chongqing Medical University · CNYebio Bioengineering (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In addition to CT images and pathological features, many other molecular characteristics remain unknown about multiple primary lung cancer (MPLC) from intrapulmonary metastatic lung cancer. Case presentation: In this study, we reported a patient with an early-stage MPLC with both adenocarcinoma Conclusion: Generally, in addition to CT imaging and pathological results, genomic profiling and tumor microenvironments may facilitate identifying the potential molecular mechanisms and clinical outcomes in patients with early-stage MPLC.

Indexed as

genomic profilingmulti-omics analysesmultiple primary lung cancerthree-dimensional (3D) reconstructiontumor environment

Identifiers

PMID37205198
PMCPMC10185815
OpenAlexW4367678842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.